France‘s Winter Health Monitoring: Current Status (January 19,2026)
As of January 19,2026,France is currently experiencing ongoing winter epidemics of influenza,bronchiolitis,and COVID-19. The French National Agency for the Safety of Medicines and Health Products (ANSM) convened the monitoring committee for the 2025-2026 winter plan on January 15, 2026, including representatives from patient groups, healthcare professionals, the pharmaceutical supply chain, and government institutions. Supply of essential medicines remains sufficient to meet patient needs.
Epidemiological Situation
Influenza
according to the latest data from Santé Publique France,the influenza epidemic continues across most of mainland France. The island of Réunion is currently in a pre-epidemic phase.
Bronchiolitis
The bronchiolitis epidemic is receding both in primary care settings and in hospitals. Seven regions have now exited the epidemic phase, and the situation in the Île-de-France region has returned to normal levels. Santé Publique France provides detailed updates on bronchiolitis trends.
COVID-19
The number of identified COVID-19 cases remains stable at a low level. Santé Publique France continues to monitor COVID-19 activity.
Medicine and Supply Monitoring
The ANSM is closely monitoring 14 sentinel molecules as part of the winter plan.These include:
- Antibiotics: Amoxicillin, Amoxicillin/clavulanic acid, Azithromycin, and Clarithromycin
- Fever Reducers: Paracetamol
- Corticosteroids: Prednisolone
- Asthma Treatments: Fluticasone and Salbutamol
Stocks of these sentinel molecules are currently at satisfactory levels across the entire pharmaceutical supply chain – including manufacturers, wholesalers, and pharmacies. No shortages have been reported,and patient needs are being met. Continuous monitoring also extends to essential medical devices, including those used in pediatric and adult intensive care, and rapid diagnostic tests (TROD).
Data Availability
Weekly data on the 14 sentinel molecules is available on the ANSM website.
key Takeaways
- Winter epidemics of influenza, bronchiolitis, and COVID-19 are currently active in France.
- The supply of essential medicines is sufficient to meet current demand.
- The ANSM is actively monitoring the situation and ensuring the availability of critical medications and medical devices.
- The bronchiolitis epidemic is receding, with several regions returning to normal levels.